Michigan State University
Flint, Michigan, 48502, United States
NCT Number: NCT05358964
The understanding, utilization and uptake of Family Health History is essential to the prevention of health disparities in the African American community. Creating a culturally tailored Family Health History tool, co-developed by members of the African American community will inform, educate and empower African Americans about health issues related to their family genealogy. Applying the knowledge gained via Family Health Histories to increase preventative behaviors including screenings thus linking people to needed health services to prevent the onset of disease and illness.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Flint, Michigan, 48502, United States
African Americans (AA) suffer disproportionately across most health disparities (HD). Preventative behaviors including screenings can inform proactive measures to address many HD which include: diabetes, heart disease, high blood pressure, stroke, HIV, STDs/STIs, cancer, and cardiovascular disease, most of which can be prevented.1-3 Evidence suggests that a lack of general health literacy (HL) and racially appropriate health communication strategies may contribute to the consistent high rates of health disparities in the AA community. Family Health Histories (FHH), which describe genetic and other familial contributions to health, have been identified as an effective tool for prevention and early detection and screenings. The underutilization of FHHs in AA communities negatively impacts screening and preventative measures that could prevent the onset of disease, illness and ultimately death.4 Although many FHH toolkits have been created to assist families in gathering FHH information, these tools typically are mostly focused for the general population and do not account for the cultural and ethnic nuances, communication preference and health literacy levels of the African American community.4 The failure to effectively engage AA in the creation and conception of culturally relevant FHH tools and activities to date likely contributes to their underutilization in this population.
The objective of this K01 is to develop culturally appropriate FHH tools designed for broad understanding and uptake in AA communities. The central hypothesis of this proposal is that, using a community based participatory research (CBPR) approach, co-development of a culturally appropriate FHH toolkit will increase the utility and engagement of AA families in FHH activities; increase effective health communication within the family structure; and increase the health literacy of participants in a multifaceted effort to reduce and ultimately eliminate racial and ethnic health disparities. Flint is an ideal community in which to conduct this participatory research because the recent events of the Flint Water Crisis have created interest in genetics and FHH in the AA community as a result of community concern around the generational impacts of bacteria and lead exposure on health. Therefore, we will have partners within AA communities in Flint who will be motivated to partner with us to develop these tools for Flint and for other minority communities.
This career development award is being submitted by Dr. Kent Key, a candidate with extensive experience in CBPR and a solid foundation in qualitative and health disparities research. To reach his long term goal of becoming an R01-funded researcher in CBPR to reduce health disparities by increasing health literacy and using effective health communication strategies to reduce and ultimately eliminate racial health disparities for African-American populations, this K01 will provide additional training in the following areas: (1) intervention development and design and conduct of randomized trials, (2) health communication models, (3) health literacy promotion, (4) CBPR approaches to Genomics and Genetics, (5) biostatistics, (6) grant-writing.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The AAFHHEP arm is an intervention to increase utilization of FHH and increase preventative screening. This tool will be culturally tailored by African Americans for African Americans.
Other names: AAFHHEP
Time frame: 3 month
We will evaluate the length of conversations (minutes per month) with family using a modified Genetic Alliance Assessment
Time frame: 3 months
We will evaluate the length of conversations (minutes per month) with physician using a modified Genetic Alliance Assessment
Time frame: 3 months
We will evaluate the quality of conversations using the Genetic Alliance Assessment
Time frame: 6 months
We will evaluate the quality of conversations using the Genetic Alliance Assessment
Time frame: 3 months
End of Intervention/Treatment Questionnaire: This is a descriptive measure, positive experiences described meaning higher acceptability
Time frame: 6 months
End of Intervention/Treatment Questionnaire: This is a descriptive measure, positive experiences described meaning higher acceptability
Time frame: 3 months
End of Intervention/Treatment Questionnaire: This is a descriptive measure, positive experiences described meaning higher acceptability
Time frame: 6 months
End of Intervention/Treatment Questionnaire: This is a descriptive measure, positive experiences described meaning higher acceptability
Time frame: 3 months
CSQ-8-R: scores range from 8-32, higher scores indicating higher satisfaction
Time frame: 6 months
CSQ-8-R: scores range from 8-32, higher scores indicating higher satisfaction
Time frame: 3 months
CSQ-8-R: scores range from 8-32, higher scores indicating higher satisfaction
Time frame: 6 months
CSQ-8-R: scores range from 8-32, higher scores indicating higher satisfaction
Time frame: 3 months
We will evaluate satisfaction using the the Client Satisfaction Questionnaire (CSQ-8-R)
Time frame: 6 months
We will evaluate satisfaction using the the Client Satisfaction Questionnaire (CSQ-8-R)
Time frame: 3 months
We will evaluate understandability using the Health Literacy Questionnaire (HLQ)
Time frame: 6 months
We will evaluate understandability using the Health Literacy Questionnaire (HLQ)
Time frame: 3 months
We will evaluate number of screenings requested using the Family Health Communication Quotient (FHCQ)
Time frame: 6 months
We will evaluate number of screenings requested using the Family Health Communication Quotient (FHCQ)
Time frame: 3 months
We will evaluate health literacy using the Health Literacy Questionnaire (HLQ)
Time frame: 6 months
We will evaluate health literacy using the Health Literacy Questionnaire (HLQ)
Time frame: 3 months
We will evaluate health communication using the Health Literacy Questionnaire (HLQ)
Time frame: 6 months
We will evaluate health communication using the Health Literacy Questionnaire (HLQ)
Michigan State University
Other
Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the African American Community
Acronym: FHH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06157983
Arterial Occlusive Diseases, Arteriosclerosis
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT07718971
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Critical Illness
Seattle, Washington, United States
View Trial DetailsNCT05721326
Adnexal Diseases, Breast Cancer Female
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06549725
Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Prague, Czechia
View Trial Details